ANI Pharmaceuticals Inc

2026-08-24 20:13; UTC

ANI Pharmaceuticals Inc. shares are higher in after-market trading, recovering from four consecutive sessions of losses amid ongoing geopolitical concerns.

2026-08-21 20:01; UTC

ANI Pharmaceuticals Inc. shares are lower today, continuing a decline since Thursday's close and trading near the lower end of its one-month range.

2026-08-20 19:46; UTC

ANI Pharmaceuticals is trading lower today, having peaked earlier in the session. The stock remains below its 20-day moving average amid strong labor market data.

2026-08-19 23:41; UTC

ANI Pharmaceuticals Inc. shares declined after-market, falling sharply below the 20-day moving average and near the lower end of their one-month trading range.

2026-08-18 20:12; UTC

ANI Pharmaceuticals shares are higher in after-market trading, despite no specific news. The asset remains near the lower end of its one-month range.

2026-08-17 19:36; UTC

ANI Pharmaceuticals reports $266 million in Q2 revenue, exceeding estimates. However, shares are lower amid guidance concerns and broader market declines.

2026-08-14 19:26; UTC

ANI Pharmaceuticals is trading higher, recovering from an early drop amid broader market concerns following a decline in U.S. retail sales for July.

2026-08-13 22:16; UTC

ANI Pharmaceuticals Inc. shares showed routine trading activity in after-market hours, remaining roughly flat since Thursday's close and near the lower end of its one-month range.

2026-08-12 19:36; UTC

ANI Pharmaceuticals Inc shares are higher during Wednesday's session amid a broader market optimism following a modest increase in inflation data.

2026-08-11 19:56; UTC

ANI Pharmaceuticals shares are lower despite a 25.9% sales increase to $266 million. Full-year revenue guidance of $1.11 billion fell short of estimates.

2026-08-10 20:01; UTC

ANI Pharmaceuticals shares are lower today as analysts cut price targets, despite strong Q2 earnings that exceeded estimates and revenue growth.

2026-08-07 20:03; UTC

ANI Pharmaceuticals shares are lower after reporting Q2 revenue of $266 million and providing full-year guidance of $1.11 billion, below analyst estimates.

2026-08-06 19:51; UTC

ANI Pharmaceuticals shares are rising amid high trading volume ahead of its Q2 earnings report. Analysts expect revenue growth to decelerate compared to last year.

2026-08-05 20:06; UTC

ANI Pharmaceuticals Inc shares are higher today, though no specific news explains the move. Market sentiment has improved amid a decline in crude oil prices.

2026-08-04 19:33; UTC

ANI Pharmaceuticals is declining today despite noted revenue growth and improved cash flow margins, as sector regulation raises caution about earnings potential.

2026-08-03 19:46; UTC

ANI Pharmaceuticals is trading higher since Friday's close, despite a flat overall session. The stock remains near the lower end of its one-month range.

2026-07-31 20:06; UTC

ANI Pharmaceuticals Inc. shares are declining amid unusual volatility, with trading lower since Thursday as inflation concerns rise alongside US Treasury yields and crude oil prices.

2026-07-30 20:09; UTC

ANI Pharmaceuticals Inc. shares are lower during Thursday's session, following a notable dip in late morning trading amid mixed economic signals impacting broader market conditions.

2026-07-29 19:19; UTC

ANI Pharmaceuticals shares are higher, rebounding after an earlier pullback. Market sentiment is influenced by expectations for the Federal Reserve's monetary policy announcement today.

2026-07-28 20:02; UTC

ANI Pharmaceuticals is advancing today, continuing an upward trend since Monday, despite declines in broader market sectors, particularly technology stocks in Asia.

2026-07-24 20:06; UTC

ANI Pharmaceuticals shares are lower today amid mixed market sentiment for healthcare stocks. The company plans to discuss its Q2 2026 financial results on August 7, 2026.

2026-07-22 20:01; UTC

Shares of ANI Pharmaceuticals are lower amid concerns over potential tariffs on imported generic drugs. The stock is near the lower end of its one-month range.

2026-07-21 20:12; UTC

ANI Pharmaceuticals Inc. shares are lower in after-market trading, positioned below the 20-day moving average and near the lower end of their one-month range.

2026-07-20 19:46; UTC

ANI Pharmaceuticals shares are lower despite positive results from the Phase 4 SYNCHRONICITY trial, which may support expanded use of ILUVIEN.